Menu

布地奈德缓释胶囊不同版本一盒的最新价格公布

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

In the treatment of Crohn's disease, a complex and challenging intestinal inflammatory disease, budesonide sustained-release capsules have become a trusted treatment option for many patients and doctors due to their unique anti-inflammatory effects and good tolerability. It greatly improves patients' quality of life by reducing intestinal inflammation and effectively relieving abdominal pain, diarrhea and systemic symptoms caused by Crohn's disease. As market dynamics change, the price information of different versions of budesonide extended-release capsules has also been updated, providing patients with more cost-effective choices. The following is a detailed analysis of the latest prices of several popular versions of budesonide extended-release capsules currently on the market, together with a description of the contraindications of the drug.

Budenesonide sustained-release capsulesLatest price overview

1. German original budesonide sustained-release capsules

The current market price of 3mg × 100 capsules is about $1,500.

2. Dr. Falk Pharma GmbH of Germany produces and exports the Turkish version

3mg×100 capsules costs about $940.

3. Italian version of budesonide sustained-release capsules

3mg × 50 capsules is about 980$.

The first and absolute contraindication is patients with an allergic reaction to budesonide or its components. Such patients may experience severe allergic reactions after use, including but not limited to dyspnea, rash, urticaria, angioedema, etc., which may even be life-threatening. Therefore, before use, patients should inform their doctor in detail about their allergic history and conduct necessary allergy tests to avoid uncomfortable symptoms during re-use.

Although this article does not list them in detail, patients should also pay attention to other potential contraindications and precautions when using budesonide sustained-release capsules, such as restrictions on use in special circumstances such as severe liver damage, pregnancy and lactating women. These decisions need to be made under the guidance of a doctor to ensure the rationality of treatment.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。